Week In Review: Fosun's Gland Pharma Approved For $814 Million IPO In India

India's Gland Pharma, a majority-owned subsidiary of Shanghai Fosun Pharma, was approved for an $814 million IPO on India's Sebi exchange (see story). The Hyderabad-based drug company makes generic injectible drugs for international markets.